4 research outputs found
HPLC-based purification and isolation of potent anti-HIV and latency reversing Daphnane Diterpenes from the medicinal plant Gnidia sericocephala (Thymelaeaceae)
Despite the success of combination antiretroviral therapy (cART), HIV persists in low- and
middle-income countries (LMIC) due to emerging drug resistance and insufficient drug accessibility.
Furthermore, cART does not target latently-infected CD4+ T cells, which represent a major barrier to
HIV eradication. The “shock and kill” therapeutic approach aims to reactivate provirus expression in
latently-infected cells in the presence of cART and target virus-expressing cells for elimination. An
attractive therapeutic prototype in LMICs would therefore be capable of simultaneously inhibiting
viral replication and inducing latency reversal. Here we report that Gnidia sericocephala, which is
used by traditional health practitioners in South Africa for HIV/AIDS management to supplement
cART, contains at least four daphnane-type compounds (yuanhuacine A (1), yuanhuacine as part
of a mixture (2), yuanhuajine (3), and gniditrin (4)) that inhibit viral replication and/or reverse HIV
latency. For example, 1 and 2 inhibit HIV replication in peripheral blood mononuclear cells (PBMC)
by >80% at 0.08 g/mL, while 1 further inhibits a subtype C virus in PBMC with a half-maximal
effective concentration (EC50) of 0.03 M without cytotoxicity. Both 1 and 2 also reverse HIV latency
in vitro consistent with protein kinase C activation but at 16.7-fold lower concentrations than the
control prostratin. Both 1 and 2 also reverse latency in primary CD4+ T cells from cART-suppressed
donors with HIV similar to prostratin but at 6.7-fold lower concentrations. These results highlight G.
sericocephala and components 1 and 2 as anti-HIV agents for improving cART efficacy and supporting
HIV cure efforts in resource-limited regions.SUPPLEMENTARY MATERIAL : TABLE S1: Anti-HIV replication activity of the positive control efavirenz using the in vitro deCIPhR assay: TABLE S2: Anti-HIV replication activity of G. sericocephala root extracts using the in vitro deCIPhR assay: TABLE S3: Cytotoxicity of G. sericocephala root extracts using the in vitro deCIPhR assay; FIGURE S1: 1H NMR data of yuanhuacine A (1), acquired on a Bruker Avance III HD 500 MHz NMR spectrophotometer with Prodigy Probe, the compound dissolved in deuterated chloroform (CDCl3): FIGURE S2: 13C NMR data of yuanhuacine A (1), acquired on a Bruker Avance III HD 500 MHz NMR spectrophotometer with Prodigy Probe, the compound dissolved in deuterated chloroform (CDCl3): FIGURE S3: The DEBT NMR data of yuanhuacine A (1), acquired on a Bruker Avance III HD 500 MHz NMR spectrophotometer with Prodigy Probe, the compound dissolved in deuterated chloroform (CDCl3).Funding was provided by the South African Department of Science and Innovation
(DST/CON 0031/2019), Canadian Institutes for Health Research (CIHR PJT-153057) (I.T.) and the New
Frontiers in Research Fund—Explorations (NFRFE-2018-01386) (I.T.). This work was also supported
through the Sub-Saharan African Network for TB/HIV Research Excellence (SANTHE) (I.T.; N.G.),
a DELTAs African Initiative [grant # DEL-15-006]. The DELTA African Initiative is an independent
funding scheme of the African Academy of Sciences (AAS)’s Alliance for Accelerating Excellence
in Science in Africa (AESA) and supported by the New Partnership for Africa’s Development
Planning and Coordinating Agency (NEPAD Agency) with funding from the Welcome Trust [grant #
107752/Z/15/Z] and the UK government. This work was also supported by grants to L.J.M.: Beyond
Antiretroviral Treatment (BEAT)-HIV Delaney Collaboratory Grants UM1AI126620 and UM1AI64570.
It was also supported by the Robert I. Jacobs Fund of the Philadelphia Foundation; Penn Center for
AIDS Research Grant P30 AI 045880; and the Herbert Kean. The APC was funded by University of
Pretoria and Deaprtment of Science and Innovation.https://www.mdpi.com/journal/virusesam2023Chemistr
Phenotypic Characterization of Allelic Variation within the HEAT Repeats of the Mechanistic Target of Rapamycin (mTOR)
The mammalian target of rapamycin (mTOR) is a kinase responsible for cell growth and metabolism and has been linked to tumor growth. An allelic variant (R628C) found in the HEAT repeats of mTOR, found in Balb/c mice, contributes to tumor susceptibility. HEAT repeats are known to be sites of protein-protein interactions, dimerization, and allow for proper localization. The goal of this study is to further elucidate the functional significance of HEAT repeats in TOR biology and show how allelic variation in the HEAT repeats may contribute to tumor susceptibility. Our results have shown differential binding of mTORC1/2 partners to mTOR in cells expressing the allelic variant. Studies are ongoing to assess binding to other mTORC1/2 complex partners, dimerization, and localization of the allelic variant. Our findings will model activation of mTOR signaling
The Regulation of DNA Methylation by the HOXA13 gene within Glioblastoma Cells
Funded through a grant provided by the national Tri-Beta biology honors program, this project not only provides a potential way of controlling tumor progression, but it also delivers a possibility of how DNA methylation rates can be used to understand brain cancer. Using techniques such as human cell culture, western blotting, methylated DNA quantification, and CRISPR/CAS9, the project looks into the specific mechanism of hyper-methylation. Previously published literature linked homeobox genes to brain cancer (glioblastoma), but it was unclear why the two had a correlation. This project proposes that the missing link is the DNA methylation happening within the cells controlled by homeobox genes
Intact HIV reservoir estimated by the intact proviral DNA assay correlates with levels of total and integrated DNA in the blood during suppressive antiretroviral therapy.
Accurate characterization of the HIV reservoir is imperative to develop an effective cure. HIV was measured in antiretroviral therapy-suppressed individuals using the intact proviral DNA assay (IPDA), along with assays for total or integrated HIV DNA, and inducible HIV RNA or p24. Intact provirus correlated with total and integrated HIV